The binary regression model further elucidates factors associated with a reduced risk of SCD, showing that the use of P2Y12 antagonists, better renal function (GFR > 60 mL/min), higher ejection fraction (EF), and lower body mass index (BMI) are all protective against SCD (Table 3). Here, P2RY12 is linked to Schnyder corneal dystrophy.